Loading clinical trials...
Loading clinical trials...
Impact of Continuous Intraoperative Administration of Esmolol on Nociception Level-guided Control of Nociception. The EsmoNOL Randomized Controlled Trial
Conditions
Interventions
Esmolol Hydrochloride
Saline
Locations
1
Canada
Maisonneuve-Rosemont Hospital - CIUSSS de l'Est de l'Île de Montréal
Montreal East, Quebec, Canada
Start Date
April 16, 2024
Primary Completion Date
March 3, 2025
Completion Date
March 4, 2025
Last Updated
July 16, 2024
NCT07360392
NCT07454629
NCT07365345
NCT06430957
NCT06346132
NCT06906263
Lead Sponsor
Ciusss de L'Est de l'Île de Montréal
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions